In these comments on the Buprenorphine via Telemedicine Proposed Rule, NHeLP urges the DEA to withdraw the proposed rule related to the induction of buprenorphine via telemedicine and continue the expanded telemedicine flexibilities under the Opioid Public Health Emergency.
Few individuals with opioid use disorder currently have access to medication-assisted treatment, a highly effective overdose prevention treatment. As the…